Zydus Cadila announces completion of phase-I trials of malaria drug
NEW DELHI: Ahmedabad-based Zydus Cadila Healthcare has announced that its antimalarial compound ZY19489 (MMV253) in development with Swiss-based product development...
NHM Team
India earmarks Rs 35,000 crore for COVID-19 vaccine in Union Budget
The government on Monday proposed a budget outlay of Rs 2,23,846 crore for health and wellbeing in 2021-2022, an increase...
Hello world!
Welcome to WordPress. This is your first post. Edit or delete it, then start writing!
